{"denoms":[{"counts":[{"groupId":"OG000","value":"0"}],"units":"Participants"}],"description":"Both LPI and Serum Ferritin levels are measured at screening (baseline), week 4, 12, 24 and end of study. The correlation between the levels of LPI and Serum Ferritin at screening, week 4, 12, 24 and end of study will be examined and plotted.","groups":[{"description":"Patients receive oral deferasirox once daily for up to 6 months in the absence of unacceptable toxicity.","id":"OG000","title":"Arm I"}],"populationDescription":"The enrolled patient's LPI level at baseline is below 0.5 umol/L and she had both LPI and Serum Ferritin levels measured at baseline only. Therefore, no sufficient data to estimate the correlation of LPI with Serum Ferritin.","reportingStatus":"POSTED","timeFrame":"Assessed through 6 months from the start of treatment","title":"Correlation of LPI With Serum Ferritin","type":"SECONDARY"}